These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 8210301)
1. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Hay EM; Bacon PA; Gordon C; Isenberg DA; Maddison P; Snaith ML; Symmons DP; Viner N; Zoma A Q J Med; 1993 Jul; 86(7):447-58. PubMed ID: 8210301 [TBL] [Abstract][Full Text] [Related]
2. Definition and treatment of lupus flares measured by the BILAG index. Gordon C; Sutcliffe N; Skan J; Stoll T; Isenberg DA Rheumatology (Oxford); 2003 Nov; 42(11):1372-9. PubMed ID: 12810926 [TBL] [Abstract][Full Text] [Related]
3. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Isenberg DA; Rahman A; Allen E; Farewell V; Akil M; Bruce IN; D'Cruz D; Griffiths B; Khamashta M; Maddison P; McHugh N; Snaith M; Teh LS; Yee CS; Zoma A; Gordon C Rheumatology (Oxford); 2005 Jul; 44(7):902-6. PubMed ID: 15814577 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. Ward MM; Marx AS; Barry NN J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805 [TBL] [Abstract][Full Text] [Related]
5. Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group. Wollaston SJ; Farewell VT; Isenberg DA; Gordon C; Merrill JT; Petri MA; Kalunian KC; J Rheumatol; 2004 Dec; 31(12):2390-4. PubMed ID: 15570639 [TBL] [Abstract][Full Text] [Related]
6. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Symmons DP; Coppock JS; Bacon PA; Bresnihan B; Isenberg DA; Maddison P; McHugh N; Snaith ML; Zoma AS Q J Med; 1988 Nov; 69(259):927-37. PubMed ID: 3271336 [TBL] [Abstract][Full Text] [Related]
7. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission. Wais T; Fierz W; Stoll T; Villiger PM J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Brunner HI; Feldman BM; Bombardier C; Silverman ED Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262 [TBL] [Abstract][Full Text] [Related]
9. Development of a clinical chart to compute different disease activity indices for systemic lupus erythematosus. Vitali C; Bencivelli W; Mosca M; Carrai P; Sereni M; Bombardieri S J Rheumatol; 1999 Feb; 26(2):498-501. PubMed ID: 9972994 [TBL] [Abstract][Full Text] [Related]
11. Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia. Ripley BJ; Goncalves B; Isenberg DA; Latchman DS; Rahman A Ann Rheum Dis; 2005 Jun; 64(6):849-53. PubMed ID: 15897306 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the clinical activity of systemic lupus erythematosus]. Le Loët X Ann Med Interne (Paris); 1990; 141(3):261-4. PubMed ID: 2195948 [TBL] [Abstract][Full Text] [Related]
13. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients. Lu TY; Ng KP; Cambridge G; Leandro MJ; Edwards JC; Ehrenstein M; Isenberg DA Arthritis Rheum; 2009 Apr; 61(4):482-7. PubMed ID: 19333973 [TBL] [Abstract][Full Text] [Related]
14. The Rheumatology Attitudes Index and its helplessness subscale are valid and reliable measures of learned helplessness in Asian patients with systemic lupus erythematosus. Thumboo J; Fong KY; Chan SP; Leong KH; Feng PH; Thio ST; Boey ML J Rheumatol; 1999 Jul; 26(7):1512-7. PubMed ID: 10405938 [TBL] [Abstract][Full Text] [Related]
15. Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus. Gordon C; Wallace DJ; Shinada S; Kalunian KC; Forbess L; Braunstein GD; Weisman MH Rheumatology (Oxford); 2008 Mar; 47(3):334-8. PubMed ID: 18238794 [TBL] [Abstract][Full Text] [Related]
16. Outcome measures to be used in clinical trials in systemic lupus erythematosus. Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993 [TBL] [Abstract][Full Text] [Related]
17. Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus. Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA Ann Rheum Dis; 1996 Oct; 55(10):756-60. PubMed ID: 8984942 [TBL] [Abstract][Full Text] [Related]
18. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices. Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044 [TBL] [Abstract][Full Text] [Related]
19. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159 [TBL] [Abstract][Full Text] [Related]
20. British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus. Yee CS; Farewell V; Isenberg DA; Rahman A; Teh LS; Griffiths B; Bruce IN; Ahmad Y; Prabu A; Akil M; McHugh N; D'Cruz D; Khamashta MA; Maddison P; Gordon C Arthritis Rheum; 2007 Dec; 56(12):4113-9. PubMed ID: 18050213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]